FDA NDC Directory · JSON-LD · Markdown

PALIPERIDONE

NDC 43975-352 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerANI Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA204452
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsPALIPERIDONE (9 mg/1)
Marketing started20191127
Package count1

External sources

Source: openFDA. Public-domain (CC0).